SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MIRANDOLA, Prisco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.075
EU - Europa 502
AS - Asia 434
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 1
Totale 3.015
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.070
CN - Cina 221
UA - Ucraina 130
DE - Germania 124
SG - Singapore 106
TR - Turchia 95
GB - Regno Unito 71
IT - Italia 53
SE - Svezia 43
FI - Finlandia 38
RU - Federazione Russa 17
BE - Belgio 15
FR - Francia 8
CA - Canada 5
HK - Hong Kong 5
EU - Europa 3
IR - Iran 3
CZ - Repubblica Ceca 2
JP - Giappone 2
AR - Argentina 1
BD - Bangladesh 1
LT - Lituania 1
TW - Taiwan 1
Totale 3.015
Salva come PNG Salva come JPEG
Città #
Woodbridge 319
Fairfield 244
Chandler 159
Jacksonville 149
Houston 140
Seattle 110
Ann Arbor 103
Santa Clara 102
Ashburn 99
Wilmington 94
Singapore 90
Cambridge 87
Izmir 62
Nanjing 46
Beijing 33
Princeton 31
Addison 30
Boardman 26
Dearborn 26
Ferrara 22
Shanghai 20
Nanchang 18
San Diego 18
Bremen 15
Brussels 15
Milan 14
Los Angeles 13
Shenyang 13
Changsha 12
Hebei 10
San Mateo 10
Auburn Hills 8
Falls Church 8
Jiaxing 8
Jinan 8
Tianjin 8
Helsinki 7
Kunming 7
New York 6
Hong Kong 5
Mountain View 5
Philadelphia 5
Chicago 4
London 4
Norwalk 4
Tappahannock 4
Zhengzhou 4
Des Moines 3
Guangzhou 3
Haikou 3
Hefei 3
Lanzhou 3
Munich 3
Redmond 3
Taizhou 3
Toronto 3
Brno 2
Frankfurt am Main 2
Hangzhou 2
Ningbo 2
Osaka 2
Redwood City 2
Ardabil 1
Augusta 1
Buenos Aires 1
Chiswick 1
Falkenstein 1
Hounslow 1
Indiana 1
Lappeenranta 1
Lavello 1
Monmouth Junction 1
Orange 1
Palma Campania 1
Parma 1
Shaoxing 1
Sunnyvale 1
Taipei 1
Verona 1
Zibo 1
Totale 2.282
Salva come PNG Salva come JPEG
Nome #
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 162
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 133
HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells 127
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 125
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 123
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 119
Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication 118
MODULATION OF THE AKT/RAS/RAF/MEK/ERK PATHWAY BY A3 ADENOSINE RECEPTOR 118
Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells 113
null 112
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 109
Engagement of CD28 modulates CXC chemokine receptor 4 surface expression in both resting and CD3-stimulated CD4+ T cells 107
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 105
NK-active cytokines IL-2, IL-12 and IL-15 selectively modulate specific protein kinase C (PKC) isoforms in primary human NK cells. 97
null 90
Infection of CD34+ hematopoietic progenitor cells by human herpesvirus 7 (HHV-7) 90
Stromal derived factor-1 induces apoptosis in activated primary CD4+ T cells. 89
null 88
null 86
Cytotoxic drugs regulate VEGF and IL-8 expression in human melanoma cells by A2A and A3 adenosine receptors. 86
Human herpesvirus 7 infection impairs the survival/differentiation of megakaryocytic cells 79
Cannabinoid CB2 receptor modulates microglial cell activation: role of ERK-1/2 Kinase signaling. 77
A3 adenosine receptors modulate hypoxia-inducible factor-1-alpha expression in human A375 melanoma cells 74
Growth regulation of tumor cells in hypoxia: Focus on A3 adenosine receptors. 74
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells 73
Adenosine receptors as mediators of both cells proliferation and cells death of cultured human melanoma cells. 72
A3 ADENOSINE RECEPTORS MODULATE HYPOXIA-INDUCIBLE FACTOR-1ALPHA EXPRESSION IN HUMAN CANCER CELLS 68
null 66
VEGF and IL-8 regulation by cytotoxic drugs in human melanoma cells: molecular mechanism modulated by A2B and A3 adenosine receptors 64
Vascular endothelial growth factor regulation by adenosine via hypoxia-inducible factor-1 in hypoxic human glioblastoma cells. 60
Adenosine Receptors in Colon Carcinoma Tissues and Colon Tumoral Cell Lines: Focus on the A3 Adenosine Subtype 37
Activation of the nitric oxide synthase pathway represents a key component of the TNF-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity on hematological malignancies. 32
A2B AND A3 ADENOSINE RECEPTORS MODULATE VASCULAR ENDOTHELIAL GROWTH FACTOR AND INTERLEUKIN-8 EXPRESSION IN HUMAN MELANOMA CELLS TREATED WITH ETOPOSIDE AND DOXORUBICIN. 29
Human herpesvirus 7 induces the functional up-regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) coupled to TRAIL-R1 down-modulation in CD4+ T cells. 27
Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway 11
Keep neuroinflammation in mind when addressing Alzheimer's disease: A microglia perspective 2
Totale 3.042
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.478
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.478
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020269 0 0 0 0 0 0 66 67 49 62 11 14
2020/2021368 37 50 7 55 11 39 13 43 5 36 50 22
2021/2022329 5 37 17 17 12 16 9 14 10 29 28 135
2022/2023346 35 40 10 44 74 45 11 17 38 2 21 9
2023/2024119 20 16 6 3 9 9 10 3 5 4 0 34
2024/2025280 16 21 52 32 108 51 0 0 0 0 0 0
Totale 3.042